Your browser doesn't support javascript.
loading
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT.
Bug, Gesine; Labopin, Myriam; Niittyvuopio, Riitta; Stelljes, Matthias; Reinhardt, Hans Christian; Hilgendorf, Inken; Kröger, Nicolaus; Kaare, Ain; Bethge, Wolfgang; Schäfer-Eckart, Kerstin; Verbeek, Mareike; Mielke, Stephan; Carlson, Kristina; Bazarbachi, Ali; Spyridonidis, Alexandros; Savani, Bipin N; Nagler, Arnon; Mohty, Mohamad.
Affiliation
  • Bug G; Goethe University, Department of Medicine 2, Frankfurt am Main, Germany. g.bug@em.uni-frankfurt.de.
  • Labopin M; Sorbonne University, Department of Hematology, Saint Antoine Hospital, INSERM UMR 938, Paris, France.
  • Niittyvuopio R; HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland.
  • Stelljes M; University of Muenster, Department of Hematology/Oncology, Muenster, Germany.
  • Reinhardt HC; University Hospital Essen, Department of Hematology and Stem Cell Transplantation, Essen, Germany.
  • Hilgendorf I; Universitätsklinikum Jena, Klinik für Innere Medizin II (Abt. Hämatologie und Onkologie) Am Klinikum 1, Jena, Germany.
  • Kröger N; Department for Stem Cell Transplantation, University Medical Center, Hamburg, Germany.
  • Kaare A; Tartu University Hospital, Clinic of Hematology and Oncology, Tartu, Estonia.
  • Bethge W; Universität Tuebingen, Medizinische Klinik, Tuebingen, Germany.
  • Schäfer-Eckart K; Klinikum Nuernberg, 5. Medizinische Klinik, BMT-Unit, Nuernberg, Germany.
  • Verbeek M; Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Clinic and Policlinic for Internal Medicine III, Munich, Germany.
  • Mielke S; Karolinska Institutet and University Hospital, LabMed, CAST, Karolinska Comprehensive Cancer Center, Stockholm, Sweden.
  • Carlson K; University Hospital, Department of Haematology, Uppsala, Sweden.
  • Bazarbachi A; Bone marrow Transplant Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Spyridonidis A; Bone Marrow Transplantation Division, University Hospital Patras, Patras, Greece.
  • Savani BN; Long term Transplant Clinic, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Nagler A; Chaim Sheba Medical Center, Department of Bone Marrow Transplantation, Tel Hashomer, Israel.
  • Mohty M; Sorbonne University, Department of Hematology, Saint Antoine Hospital, INSERM UMR 938, Paris, France.
Bone Marrow Transplant ; 58(6): 710-716, 2023 06.
Article in En | MEDLINE | ID: mdl-37002412
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2023 Type: Article Affiliation country: Germany